South Plains Oncology Consortium

The South Plains Oncology Consortium (SPOC) is a clinical trials consortium and research organization dedicated to developing new therapies for pediatric and adult cancers. Based at the Texas Tech University Health Sciences Center, SPOC specializes in early-phase clinical trials, particularly Phase 1 and Phase 2 studies for rare and refractory malignancies such as neuroblastoma and Ewing sarcoma. The consortium bridges the gap between laboratory discovery and clinical application by providing the infrastructure for multi-institutional pharmacology-driven trials. SPOC collaborates extensively with the National Cancer Institute (NCI) and various biotechnology companies to evaluate novel drug combinations and delivery systems. Its work is characterized by a strong focus on developmental therapeutics and precision medicine in oncology.